Multiple Sclerosis CompaniesU.S. Exchanges
List of Publicly Traded Multiple Sclerosis Companies Listed on Major U.S. Exchanges
The publicly traded companies on this list are biotech, medical device, pharmaceutical or other healthcare companies that provide products and treatments relating to multiple sclerosis. It is very common for companies on this list to provide products and services in other healthcare areas in addition to multiple sclerosis.
Additional publicly traded healthcare companies and healthcare categories can be accessed through the link below:
A comparison widget that shows trend, earnings per share (EPS), P/E ratio and beta for each of the companies on this list can be accessed through the link below.
Select the company’s link to access charts, news links and company website and social media information.
Multiple Sclerosis: Mid-Cap Stocks
GW Pharmaceuticals Plc (GWPH) (Cannabinoid prescription medicines: Sativex® (multiple sclerosis); Epidiolex® (childhood epilepsy))
Multiple Sclerosis: Small-Cap Stocks
Forward Pharma (FWP) (Denmark: immunomodulatory compound dimethyl fumarate and derivatives used to treat immune disorders including multiple sclerosis and psoriasis)
Multiple Sclerosis: Micro-Cap Stocks
Brainstorm Cell Therapeutics Inc. (BCLI) (Stem cell therapies for neurodegenerative diseases)
Multiple Sclerosis: Nano-Cap Stocks
Opexa Therapeutics, Inc. (OPXA) (Personalized immunotherapy: multiple sclerosis, autoimmune diseases)